Akebia Therapeutics reported $-62421000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -33.57M 79M
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
Alnylam Pharmaceuticals ALNY:US $ -274.67M 35.32M
Ardelyx ARDX:US $ -26.93M 1.14M
Astellas Pharma 4503:JP Y 31679M 42195M
Biomarin Pharmaceutical BMRN:US $ 34.85M 8.66M
Exelixis EXEL:US $ 88.51M 3.28M
Fresenius Medical Care FME:GR € 347M 25.43M
Intercept Pharmaceuticals ICPT:US $ -20.32M 3.04M
IONIS PHARMACEUT IONS:US $ -103M 39M
Karyopharm Therapeutics KPTI:US $ -48941000 7.67M
Lexicon Pharmaceuticals LXRX:US $ -24587000 1.11M
Nektar Therapeutics NKTR:US $ -158.97M 68.7M
Opko Health OPK:US $ -86.31M 9.66M
Prothena PRTA:US $ -42.57M 4.61M
Ptc Therapeutics PTCT:US $ -148.7M 26.8M
Sanofi SAN:FP € 2660M 305M
Sarepta Therapeutics SRPT:US $ -228.09M 123.95M
Vanda Pharmaceuticals VNDA:US $ 3.79M 11.35M